Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial
Published Online: 2016-07-?
Journal: The Lancet•Publisher: Elsevier BV
Authors: Amy Qin•Anthony D Elias•Ashwin Shahir•Bartosz Chmielowski•Brian A Van Tine•Damien M Cronier•Douglas Adkins•Gary K Schwartz•Gaurav D Shah•Gregory Pennock•Ilaria Conti•Jan Cosaert•Mark Agulnik•Matthew M Cooney•Meera R Hameed•Michael B Livingston•Robert Ilaria•Robin L Jones•William D Tap
